v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Treasury Stock, Common
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2022   256.4 70.7      
Beginning balance at Dec. 31, 2022 $ 5,765 $ 3 $ (7,740) $ 10,895 $ 3,334 $ (727)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   0.5        
Issuance of common stock (58)     (58)    
Repurchase of common stock (in shares)     (0.7)      
Repurchase of common stock (129)   $ (129)      
Stock-based compensation 69     69    
Net income 289       289  
Unrealized gains on derivative instruments, net of tax 10         10
Defined benefit plan adjustments, net of income tax expense of $—, $—,$—,$— 1         1
Foreign currency translation, net of tax 10         10
Reclassification adjustments, net of tax (25)         (25)
Ending balance (in shares) at Mar. 31, 2023   256.9 71.4      
Ending balance at Mar. 31, 2023 5,932 $ 3 $ (7,869) 10,906 3,623 (731)
Beginning balance (in shares) at Dec. 31, 2022   256.4 70.7      
Beginning balance at Dec. 31, 2022 5,765 $ 3 $ (7,740) 10,895 3,334 (727)
Increase (Decrease) in Stockholders' Equity            
Net income 889          
Unrealized gains on derivative instruments, net of tax 34          
Defined benefit plan adjustments, net of income tax expense of $—, $—,$—,$— 1          
Foreign currency translation, net of tax (170)          
Ending balance (in shares) at Sep. 30, 2023   257.1 74.6      
Ending balance at Sep. 30, 2023 5,805 $ 3 $ (8,509) 10,991 4,223 (903)
Beginning balance (in shares) at Mar. 31, 2023   256.9 71.4      
Beginning balance at Mar. 31, 2023 5,932 $ 3 $ (7,869) 10,906 3,623 (731)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   0.1        
Issuance of common stock 0     0    
Repurchase of common stock (in shares)     (2.5)      
Repurchase of common stock (495)   $ (495)      
Stock-based compensation 43     43    
Net income 297       297  
Unrealized gains on derivative instruments, net of tax 22         22
Foreign currency translation, net of tax (44)         (44)
Reclassification adjustments, net of tax (7)         (7)
Ending balance (in shares) at Jun. 30, 2023   257.0 73.9      
Ending balance at Jun. 30, 2023 5,748 $ 3 $ (8,364) 10,949 3,920 (760)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   0.1        
Issuance of common stock 0     0    
Repurchase of common stock (in shares)     (0.7)      
Repurchase of common stock (145)   $ (145)      
Stock-based compensation 42     42    
Net income 303       303  
Unrealized gains on derivative instruments, net of tax 2         2
Defined benefit plan adjustments, net of income tax expense of $—, $—,$—,$— 0          
Foreign currency translation, net of tax (136)         (136)
Reclassification adjustments, net of tax (9)         (9)
Ending balance (in shares) at Sep. 30, 2023   257.1 74.6      
Ending balance at Sep. 30, 2023 $ 5,805 $ 3 $ (8,509) 10,991 4,223 (903)
Beginning balance (in shares) at Dec. 31, 2023 181.5 257.2 75.7      
Beginning balance at Dec. 31, 2023 $ 6,112 $ 3 $ (8,741) 11,025 4,692 (867)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   0.7        
Issuance of common stock (61)     (61)    
Stock-based compensation 49     49    
Net income 288       288  
Unrealized gains on derivative instruments, net of tax 34         34
Foreign currency translation, net of tax (69)         (69)
Reclassification adjustments, net of tax (9)         (9)
Ending balance (in shares) at Mar. 31, 2024   257.9 75.7      
Ending balance at Mar. 31, 2024 $ 6,344 $ 3 $ (8,741) 11,013 4,980 (911)
Beginning balance (in shares) at Dec. 31, 2023 181.5 257.2 75.7      
Beginning balance at Dec. 31, 2023 $ 6,112 $ 3 $ (8,741) 11,025 4,692 (867)
Increase (Decrease) in Stockholders' Equity            
Net income 936          
Unrealized gains on derivative instruments, net of tax 8          
Defined benefit plan adjustments, net of income tax expense of $—, $—,$—,$— (1)          
Foreign currency translation, net of tax $ 62          
Ending balance (in shares) at Sep. 30, 2024 181.6 258.1 76.5      
Ending balance at Sep. 30, 2024 $ 6,967 $ 3 $ (8,941) 11,103 5,628 (826)
Beginning balance (in shares) at Mar. 31, 2024   257.9 75.7      
Beginning balance at Mar. 31, 2024 6,344 $ 3 $ (8,741) 11,013 4,980 (911)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   0.1        
Issuance of common stock (1)     (1)    
Stock-based compensation 44     44    
Net income 363       363  
Unrealized gains on derivative instruments, net of tax 15         15
Foreign currency translation, net of tax (42)         (42)
Reclassification adjustments, net of tax (11)         (11)
Ending balance (in shares) at Jun. 30, 2024   258.0 75.7      
Ending balance at Jun. 30, 2024 6,714 $ 3 $ (8,741) 11,058 5,343 (949)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   0.1        
Issuance of common stock 1     1    
Repurchase of common stock (in shares)     (0.8)      
Repurchase of common stock (200)   $ (200)      
Stock-based compensation 46     46    
Net income 285       285  
Unrealized gains on derivative instruments, net of tax (41)         (41)
Defined benefit plan adjustments, net of income tax expense of $—, $—,$—,$— (1)         (1)
Foreign currency translation, net of tax 173         173
Reclassification adjustments, net of tax $ (8)         (8)
Ending balance (in shares) at Sep. 30, 2024 181.6 258.1 76.5      
Ending balance at Sep. 30, 2024 $ 6,967 $ 3 $ (8,941) $ 11,103 $ 5,628 $ (826)